𝛼SK or Searchbullish
OpenEvidence Vs Doximity
125 Views08 Jan 2026 08:00
TL;DR: With the launch of AI scribe Visits (August) and HIPAA-secure Dialer (December), OpenEvidence has expanded from clinical search into the $3B+ AI scribe market dominated by Abridge and Ambience and is directly taking on Doximity's core business. Sacra estimates OpenEvidence hit $150M in annualized revenue in November 2025, up ~20x year-over-year. For more, check out our full report and dataset on OpenEvidence...
What is covered in the Full Insight:
- Introduction: OpenEvidence's Expansion
- Financial Performance and Growth
- Market Strategy and Competition
- Product Development: AI Scribe Visits and Dialer
- The Future of AI in Healthcare
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- OpenEvidence Vs Doximity08 Jan 2026
x